Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Antimicrobials in farming

David N. Fisman
CMAJ January 08, 2013 185 (1) 62-63; DOI: https://doi.org/10.1503/cmaj.113-2094
David N. Fisman
Dalla Lana School of Public Health, University of Toronto, Toronto, Ont.
Roles: Associate Professor of Public Health (Epidemiology)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

I wish to applaud Barbara Sibbald for her editorial on antimicrobial use in agriculture and its implications for human health.1 I was interested to learn about the degree to which Canada lags behind other countries in regulating the agricultural use of antimicrobials.

I have 2 comments on the editorial: With respect to the article’s statement that “…quinupristin–dalfopristin, [is] our last line of defence if Staphylococcus aureus or Enterococcus infections develop resistance to vancomycin,”1 I note that vancomycin-resistant Enterococcus has been recognized for over 2 decades;2 strains of S. aureus with intermediate-level resistance to vancomycin were described in 1997, and high-level vancomycin resistant S. aureus was described (outside the laboratory) in 2002.3 The role that agricultural use of avoparcin played in the genesis of vancomycin-resistant Enterococcus in humans is controversial, but recognition of the potential links between avoparcin and vancomycin-resistant Enterococcus likely contributed to European decisions to remove this antibiotic from feeds, as mentioned in the article.4 Fortunately, however, quinpristin-dalfopristin is not the only agent with activity against multiresistant gram positive microbes. Daptomycin and linezolid are available in Canada, and other agents, such as ceftaroline, have been approved in the United States and await approval in Canada.

The editorial did not mention multi-drug resistant gram negative pathogens, including Acinetobacter species, Pseudomonas aeruginosa, and the Enterobacteraceae, including recently described strains with a novel plasmid-borne carbapenemase, some of which have actually reached a point of being effectively pan resistant to available antimicrobials.5 Such microbes are environmentally abundant in agricultural runoff, surface waters and sewage. Particularly given the tendency of resistance determinants to cluster at the microbial level, the environmental contamination associated with agricultural antibiotic use provides a source of selective pressure that gives a competitive advantage to resistant microbes.

References

    1. Sibbald B
    . Farm-grown superbugs: While the world acts, Canada dawdles. CMAJ 2012;184:1553.
    1. Gold HS,
    2. Unal S,
    3. Cercenado E,
    4. et al
    . A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci. Antimicrob Agents Chemother 1993;37:1604–9.
    1. Chang S,
    2. Sievert DM,
    3. Hageman JC,
    4. et al
    . Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003;348:1342–7.
    1. Bonten MJ,
    2. Willems R,
    3. Weinstein RA
    . Vancomycin-resistant enterococci: Why are they here, and where do they come from? Lancet Infect Dis 2001;1:314–25.
    1. Walsh TR,
    2. Toleman MA
    . The emergence of pan-resistant Gram-negative pathogens merits a rapid global political response. J Antimicrob Chemother 2012;67:1–3.

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire